Gamalate B6 was evaluated in patients
with borderline intellectual functioning or mild intellectual
development disability and found to be effective and well tolerated for ADHD and challenging behavior.
This review on anti-N-methyl D-aspartate (NMDA) receptor (anti-NMDAR) encephalitis provides a case presentation and the timeline of symptoms seen over the course of the illness. Key findings in the literature about anti-NMDAR encephalitis are highlighted to facilitate diagnostic consideration and treatment.
This review provides an overview of the pharmacologic and surgical therapies currently available and under investigation for the treatment of motor fluctuations and dyskinesia in Parkinson’s disease.
Keywords: coenzyme Q10, drugs, mitochondria, mtDNA, mitochondrial diseases, toxicity Citation: Orsucci D, Caldarazzo Ienco E, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs in Context 2019; 8: 212588. DOI: 10.7573/dic.212588 Contributions: All authors contributed
The aim of this review is to present the new and well-established uses of botulinum toxin for movement disorders.
